LAKE FOREST, Ill., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Piper Jaffray 22nd Annual Health Care Conference, Nov. 30, 2010, in New York City.
The presentation is scheduled to begin at 10:00 a.m. Eastern time on Tuesday, Nov. 30, 2010. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira’s Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.
